About Avania Clinical
Avania Clinical is a Healthcare company based in Brunswick (Australia) founded in 1988, and was acquired by Astorg Partners in June 2022. Regulatory, clinical trials, and analytic services are provided in healthcare. The company has 147 employees. Avania Clinical has completed 6 acquisitions, including Anagram Esic, Hull Associates and Imarc Research. Avania Clinical offers products and services including Strategic Consulting, Clinical Operations, and Data Analytics. Its focus areas include Biopharma Outsourcing and Diversified.
Company details
Avania was established in 1988 in Brunswick, Australia, within the clinical research sector. Regulatory compliance, clinical trial management, and data analytics services are delivered to pharmaceutical and medical device firms. Support is extended for trial design, execution, and regulatory submissions across various therapeutic areas. Operations are centered in Australia, with capabilities to address global client requirements in a structured manner.
- Headquarters Brunswick, Australia
- Employees 147
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website avaniaclinical.com
- Social LinkedIn X Facebook
- Acquired by Astorg Partners (Jun 2022)
- InvestorsKester Capital
& 1 more
- Employee Count147
- Investments & AcquisitionsAnagram Esic
& 5 more
- Acquired byAstorg Partners
(Jun 2022)
Products & Services of Avania Clinical
Avania Clinical offers a comprehensive portfolio of products and services, including Strategic Consulting, Clinical Operations, and Data Analytics.
Offers regulatory and development strategies for medical technologies.
Manages trials and data for medical device advancements.
Provides safety and compliance analysis for biotech products.
Funding Insights of Avania Clinical
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Avania Clinical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2016 | Private Equity Round | β | Kester Capital | β |
2 investors in total: 2 institutional.
Investors in Avania Clinical
Avania Clinical has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Kester Capital and Astorg.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Kester Capital is focused on private equity investments in technology and life sciences sectors. | kestercapital.com | London, United Kingdom | ||
Astorg is engaged in private equity investment management. | astorg.com | Paris, France |
Investor details for Avania Clinical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Avania Clinical
30 people are tracked at Avania Clinical (10 in leadership, 20 in team); the tracked headcount is 147.
| Name | Role | Group |
|---|---|---|
Deborah Bell | Executive Director, Business Development (AUS) | Leadership |
Anne Leijsen | Director, Medical Writing | Leadership |
Megan Williams (Yee) | Associate Director Biostatistics | Leadership |
Jasmine Saba | Senior Vice President, Strategic Relationships | Leadership |
Aleksandra (Ola) Modrzejewska | Senior Director Legal & Company Secretary | Leadership |
Elizabeth Kane | Director Biostatistics | Leadership |
Sander L. | Global Director IT & Information Security | Leadership |
Sarah Robinson | Chief Human Resources Officer | Leadership |
Sam Kasierski | Director Of Business Development | Leadership |
Hailey Jannetty | Associate Director, Customer Solutions | Leadership |
Geerte Hoeke | Senior Medical Writer | Team |
Amber Salomons | Principal Medical Writer | Team |
Michael Adam Campbell | Legal Counsel | Team |
Els Beijer | Senior Medical Writer | Team |
Frances Bach | Medical Writer | Team |
Gala Garrod, PhD | Medical Writer | Team |
Esther J. Smits | Senior Medical Writer | Team |
Tjerk Zult, PhD | Senior Medical Writer | Team |
Razieh Taghavi | Manager Biostatistics (eu & Aus) | Team |
Thomas Mouraviev | Information Technology Systems Administrator | Team |
10 more people are available in the full profile.
Complete people profiles for Avania Clinical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Avania Clinical
Avania Clinical has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include Anagram Esic, Hull Associates and Imarc Research.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Clinical trial services and imaging core lab support are provided. | anagram-esic.com | Barcelona, Spain | 1998 | Oct 2024 | β’β’β’β’ | |
Innovative medical devices and healthcare products are commercialized comprehensively. | ironstonepd.com | Toronto, Canada | 2013 | Oct 2023 | β’β’β’β’ | |
Provider of market access and reimbursement consulting services for biopharma sector | hullassociates.com | Rockland, United States | 2007 | Oct 2023 | β’β’β’β’ | |
Clinical research services are provided to medical device companies. | maxismedical.com | San Jose, United States | 2003 | Feb 2023 | β’β’β’β’ | |
Foreign language courses are provided for all ages and levels. | imarcresearch.com | Strongsville, United States | 1999 | Jun 2021 | β’β’β’β’ | |
Healthcare consulting is specialized in for clinical and regulatory affairs. | milestonecro.com | San Diego, United States | 2011 | Oct 2017 | β’β’β’β’ |
Complete acquisition details for Avania Clinical
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Avania Clinical
9 dated milestones of Avania Clinical across 36 years, from founding to its latest funding, stage changes and deals.
- Founded Avania Clinical is founded.
- Funding First funding round.
- Acquisition Acquires MileStone Research.
- Acquisition Acquires Imarc Research.
- Exit Acquired by Astorg Partners.
- Acquisition Acquires Maxis Medical.
- Acquisition Acquires Hull Associates.
- Acquisition Acquires Ironstone Product Development.
- Acquisition Acquires Anagram Esic.
Web traffic of Avania Clinical
The website of Avania Clinical (avaniaclinical.com) receives about 6.2K visits a month and ranks #4,326,087 among all websites worldwide, #5,305 in Biotechnology and Pharmaceuticals.
- Monthly visits6.2K
▲ 47.9% vs previous month
- Unique visitors1.9K
per month
- Global rank#4,326,087
among all websites
- Category rank#5,305
Health · Biotechnology and Pharmaceuticals
- Bounce rate58%
- Pages per visit1.7
- Average visit27 sec
- DevicesDesktop 40% Β· Mobile 60%
Websites whose visitors overlap most with Avania Clinical. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| zedmed.com.au | 100% | #2,261,813 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Avania Clinical
Complete news archive for Avania Clinical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Avania Clinical
Avania Clinical was founded in 1988 and raised its 1st funding round 28 years after it was founded.
Avania Clinical is headquartered in Brunswick, Australia. It is registered at Brunswick, Victoria, Australia.
Avania Clinical has 147 employees.
Avania was established in 1988 in Brunswick, Australia, within the clinical research sector. Regulatory compliance, clinical trial management, and data analytics services are delivered to pharmaceutical and medical device firms. Support is extended for trial design, execution, and regulatory submissions across various therapeutic areas. Operations are centered in Australia, with capabilities to address global client requirements in a structured manner.
Avania Clinical offers Strategic Consulting, Clinical Operations, and Data Analytics.
Avania Clinical has made 6 acquisitions, including Anagram Esic, Hull Associates, and Imarc Research.
Avania Clinical has 2 investors. Key investors include Kester Capital, and Astorg.
Yes. Avania Clinical was acquired by Astorg Partners in June 2022.

